Wu Xiaobin sold $106K of ONC
Wu Xiaobin (President and COO) sold 280 shares of BeOne Medicines Ltd. (ONC) at $380.00 ($0.11M total) on 2026-08-25 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosed sale is small and unlikely to move the stock, but it provides transparency for investors monitoring insider behavior.
Market read
Routine insider sale with limited trading relevance.
What to watch
Potential upcoming dilution or financing that prompted the insider to exit.
Background
Form 4 filing discloses insider transactions to the SEC; such filings are primary sources of corporate insider activity.
Ticker impact
President and COO Wu Xiaobin sold 280 shares for $106,400 via a 10b5-1 plan, reducing his stake to zero.
Minimal impact; likely no significant price movement.
The sale amount is small relative to market cap and typical insider activity, so price reaction is expected to be muted.
Market effects
None; isolated insider transaction.
None; company is US-listed biotech.
Low; no broader market effect.
Counterpoint
The sale could be a routine liquidity event, not a negative signal.
Key entities
- CompanyBeOne Medicines Ltd.
Biotech company listed on Nasdaq under ticker ONC.
- IndividualWu Xiaobin
President and COO of BeOne Medicines, insider seller.
